NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|17737761|ref|NP_524227|]
View 

neprilysin 2, isoform A [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
104-761 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 759.98  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 104 VEPCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT-AERPETEPKHFRLPNLLYKACMNKTLIETLGP 182
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEeAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 183 EPITRVAERLGGWPLIKGDSWNADdswtwqeqvkKFRTAGFSMDYIIDFSIGVDLQNSTKRLIDLDQSSLAL-SREYLVK 261
Cdd:cd08662  81 KPLKPLLDKIGGLPSLDDLAAELL----------LALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLpDRDYYLD 150
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 262 GFNETLVTAYYKYMVDIAVLFGANRDLAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQAAYPYVQWVDYM 341
Cdd:cd08662 151 EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYL 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 342 NALLPEglnVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWRIHGFSVGFLSEEFRKRQLQYATALSGRQEQEARW 421
Cdd:cd08662 231 KALGPP---ADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPEPRW 307
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 422 KECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHSMATHIGYPDEMLD 501
Cdd:cd08662 308 KRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRD 387
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 502 NEKLAAYYAKLDIDpDKYFESFLGMNIFGTDYSFNKLRLPVNKTDWvrHARPAIVNAFYSSLENSIQFPAGILQGHFFNA 581
Cdd:cd08662 388 YSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEW--SMSPQTVNAYYNPSLNEIVFPAGILQPPFFDP 464
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 582 QRPKYMNFGAIGYVIGHEITHGFDDQGRQFDVKGNLRDWWHPDTQKAYLAKAKCIIEQYGNYTErATGLNLNGINTQGEN 661
Cdd:cd08662 465 DAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEV-PPGLHVNGKLTLGEN 543
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 662 IADNGGVKESYIAYRRWAEKHGPEaKLPGLDYTPEQMFWVAAGQTWCAKYRKESLKMRITTGVHSPSEFRVLGSLSNMKD 741
Cdd:cd08662 544 IADNGGLRLAYRAYKKWLKENGPE-LPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPE 622
                       650       660
                ....*....|....*....|
gi 17737761 742 FAKDFHCPEGSPMNPVQKCE 761
Cdd:cd08662 623 FAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
104-761 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 759.98  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 104 VEPCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT-AERPETEPKHFRLPNLLYKACMNKTLIETLGP 182
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEeAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 183 EPITRVAERLGGWPLIKGDSWNADdswtwqeqvkKFRTAGFSMDYIIDFSIGVDLQNSTKRLIDLDQSSLAL-SREYLVK 261
Cdd:cd08662  81 KPLKPLLDKIGGLPSLDDLAAELL----------LALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLpDRDYYLD 150
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 262 GFNETLVTAYYKYMVDIAVLFGANRDLAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQAAYPYVQWVDYM 341
Cdd:cd08662 151 EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYL 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 342 NALLPEglnVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWRIHGFSVGFLSEEFRKRQLQYATALSGRQEQEARW 421
Cdd:cd08662 231 KALGPP---ADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPEPRW 307
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 422 KECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHSMATHIGYPDEMLD 501
Cdd:cd08662 308 KRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRD 387
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 502 NEKLAAYYAKLDIDpDKYFESFLGMNIFGTDYSFNKLRLPVNKTDWvrHARPAIVNAFYSSLENSIQFPAGILQGHFFNA 581
Cdd:cd08662 388 YSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEW--SMSPQTVNAYYNPSLNEIVFPAGILQPPFFDP 464
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 582 QRPKYMNFGAIGYVIGHEITHGFDDQGRQFDVKGNLRDWWHPDTQKAYLAKAKCIIEQYGNYTErATGLNLNGINTQGEN 661
Cdd:cd08662 465 DAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEV-PPGLHVNGKLTLGEN 543
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 662 IADNGGVKESYIAYRRWAEKHGPEaKLPGLDYTPEQMFWVAAGQTWCAKYRKESLKMRITTGVHSPSEFRVLGSLSNMKD 741
Cdd:cd08662 544 IADNGGLRLAYRAYKKWLKENGPE-LPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPE 622
                       650       660
                ....*....|....*....|
gi 17737761 742 FAKDFHCPEGSPMNPVQKCE 761
Cdd:cd08662 623 FAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
100-763 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 559.00  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 100 MKPEVEPCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT--AERPETEPKHFRLPNLLYKACMNKTLI 177
Cdd:COG3590  33 MDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEeaAAAPAAAGSDEQKIGDLYASFMDEAAI 112
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 178 ETLGPEPI----TRVAErlggwplIKgdswNADDswtWQEQVKKFRTAGFSMdyIIDFSIGVDLQNSTKRLIDLDQSSLA 253
Cdd:COG3590 113 EALGLAPLkpdlARIDA-------IK----DKAD---LAALLAALHRAGVGG--LFGFGVDADLKNSTRYIAYLGQGGLG 176
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 254 LS-REYLVKGFNET--LVTAYYKYMVDIAVLFGANRDLAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQA 330
Cdd:COG3590 177 LPdRDYYLKDDEKSaeIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELRDPEKTYNPMTVAELAK 256
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 331 AYPYVQWVDYMNALlpeglNVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWR-IHGFSvGFLSEEFRKRQLQ-YA 408
Cdd:COG3590 257 LAPGFDWDAYLKAL-----GLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHlLDSAA-PYLSKAFVDANFDfYG 330
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 409 TALSGRQEQEARWKECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHS 488
Cdd:COG3590 331 KTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDWMSPETKAKALEKLAA 410
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 489 MATHIGYPDEMLDneklaayYAKLDIDPDKYFESFLGMNIFGTDYSFNKLRLPVNKTDWvrHARPAIVNAFYSSLENSIQ 568
Cdd:COG3590 411 FTPKIGYPDKWRD-------YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEW--GMTPQTVNAYYNPTMNEIV 481
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 569 FPAGILQGHFFNAQRPKYMNFGAIGYVIGHEITHGFDDQGRQFDVKGNLRDWWHPDTQKAYLAKAKCIIEQYGNYtERAT 648
Cdd:COG3590 482 FPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYDAY-EPLP 560
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 649 GLNLNGINTQGENIADNGGVKESYIAYRRWAEKHGPEaKLPGldYTPEQMFWVAAGQTWCAKYRKESLKMRITTGVHSPS 728
Cdd:COG3590 561 GLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGKEAP-VIDG--FTGDQRFFLGWAQVWRSKARDEALRQRLATDPHSPG 637
                       650       660       670
                ....*....|....*....|....*....|....*..
gi 17737761 729 EFRVLGSLSNMKDFAKDFHCPEGSPM--NPVQKCEVW 763
Cdd:COG3590 638 EFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
106-496 1.12e-128

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 388.19  E-value: 1.12e-128
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   106 PCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT-AERPETEPKHFRLPNLLYKACMNKTLIETLGPEP 184
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEeAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   185 ITRVAERLGGWPLikgdswnADDSWTWQEQVKKFRTAGfsMDYIIDFSIGVDLQNSTKRLIDLDQSSLAL-SREYLVKGF 263
Cdd:pfam05649  81 LKPLLDEIGGPLA-------NKDKFDLLETLAKLRRYG--VDSLFGFGVGPDDKNSSRNILYLDQPGLGLpDRDYYLKDR 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   264 NET---LVTAYYKYMVDIAVLFGANRDlAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQAAYPYVQWVDY 340
Cdd:pfam05649 152 DEKsaeIREAYKAYIAKLLTLLGASEE-AAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLAPGIDWKAY 230
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   341 MNALlpeGLNVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWR-IHGFSvGFLSEEFRKRQLQYATALSGRQEQEa 419
Cdd:pfam05649 231 LNAA---GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRlVRSLA-PYLSDEFRDANFEFYGTLSGTKQRP- 305
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 17737761   420 RWKECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHSMATHIGYP 496
Cdd:pfam05649 306 RWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
104-761 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 759.98  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 104 VEPCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT-AERPETEPKHFRLPNLLYKACMNKTLIETLGP 182
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEeAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 183 EPITRVAERLGGWPLIKGDSWNADdswtwqeqvkKFRTAGFSMDYIIDFSIGVDLQNSTKRLIDLDQSSLAL-SREYLVK 261
Cdd:cd08662  81 KPLKPLLDKIGGLPSLDDLAAELL----------LALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLpDRDYYLD 150
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 262 GFNETLVTAYYKYMVDIAVLFGANRDLAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQAAYPYVQWVDYM 341
Cdd:cd08662 151 EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYL 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 342 NALLPEglnVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWRIHGFSVGFLSEEFRKRQLQYATALSGRQEQEARW 421
Cdd:cd08662 231 KALGPP---ADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPEPRW 307
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 422 KECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHSMATHIGYPDEMLD 501
Cdd:cd08662 308 KRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRD 387
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 502 NEKLAAYYAKLDIDpDKYFESFLGMNIFGTDYSFNKLRLPVNKTDWvrHARPAIVNAFYSSLENSIQFPAGILQGHFFNA 581
Cdd:cd08662 388 YSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEW--SMSPQTVNAYYNPSLNEIVFPAGILQPPFFDP 464
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 582 QRPKYMNFGAIGYVIGHEITHGFDDQGRQFDVKGNLRDWWHPDTQKAYLAKAKCIIEQYGNYTErATGLNLNGINTQGEN 661
Cdd:cd08662 465 DAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEV-PPGLHVNGKLTLGEN 543
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 662 IADNGGVKESYIAYRRWAEKHGPEaKLPGLDYTPEQMFWVAAGQTWCAKYRKESLKMRITTGVHSPSEFRVLGSLSNMKD 741
Cdd:cd08662 544 IADNGGLRLAYRAYKKWLKENGPE-LPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPE 622
                       650       660
                ....*....|....*....|
gi 17737761 742 FAKDFHCPEGSPMNPVQKCE 761
Cdd:cd08662 623 FAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
100-763 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 559.00  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 100 MKPEVEPCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT--AERPETEPKHFRLPNLLYKACMNKTLI 177
Cdd:COG3590  33 MDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEeaAAAPAAAGSDEQKIGDLYASFMDEAAI 112
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 178 ETLGPEPI----TRVAErlggwplIKgdswNADDswtWQEQVKKFRTAGFSMdyIIDFSIGVDLQNSTKRLIDLDQSSLA 253
Cdd:COG3590 113 EALGLAPLkpdlARIDA-------IK----DKAD---LAALLAALHRAGVGG--LFGFGVDADLKNSTRYIAYLGQGGLG 176
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 254 LS-REYLVKGFNET--LVTAYYKYMVDIAVLFGANRDLAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQA 330
Cdd:COG3590 177 LPdRDYYLKDDEKSaeIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELRDPEKTYNPMTVAELAK 256
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 331 AYPYVQWVDYMNALlpeglNVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWR-IHGFSvGFLSEEFRKRQLQ-YA 408
Cdd:COG3590 257 LAPGFDWDAYLKAL-----GLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHlLDSAA-PYLSKAFVDANFDfYG 330
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 409 TALSGRQEQEARWKECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHS 488
Cdd:COG3590 331 KTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDWMSPETKAKALEKLAA 410
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 489 MATHIGYPDEMLDneklaayYAKLDIDPDKYFESFLGMNIFGTDYSFNKLRLPVNKTDWvrHARPAIVNAFYSSLENSIQ 568
Cdd:COG3590 411 FTPKIGYPDKWRD-------YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEW--GMTPQTVNAYYNPTMNEIV 481
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 569 FPAGILQGHFFNAQRPKYMNFGAIGYVIGHEITHGFDDQGRQFDVKGNLRDWWHPDTQKAYLAKAKCIIEQYGNYtERAT 648
Cdd:COG3590 482 FPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYDAY-EPLP 560
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 649 GLNLNGINTQGENIADNGGVKESYIAYRRWAEKHGPEaKLPGldYTPEQMFWVAAGQTWCAKYRKESLKMRITTGVHSPS 728
Cdd:COG3590 561 GLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGKEAP-VIDG--FTGDQRFFLGWAQVWRSKARDEALRQRLATDPHSPG 637
                       650       660       670
                ....*....|....*....|....*....|....*..
gi 17737761 729 EFRVLGSLSNMKDFAKDFHCPEGSPM--NPVQKCEVW 763
Cdd:COG3590 638 EFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
106-496 1.12e-128

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 388.19  E-value: 1.12e-128
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   106 PCDNFYEFACGTYLEEENIPDDKVSISTFSVISDKLQEQLKDIIT-AERPETEPKHFRLPNLLYKACMNKTLIETLGPEP 184
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEeAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   185 ITRVAERLGGWPLikgdswnADDSWTWQEQVKKFRTAGfsMDYIIDFSIGVDLQNSTKRLIDLDQSSLAL-SREYLVKGF 263
Cdd:pfam05649  81 LKPLLDEIGGPLA-------NKDKFDLLETLAKLRRYG--VDSLFGFGVGPDDKNSSRNILYLDQPGLGLpDRDYYLKDR 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   264 NET---LVTAYYKYMVDIAVLFGANRDlAKTELLLSLEFEMALANISWPNEKRRNSSELYNLRTPAQLQAAYPYVQWVDY 340
Cdd:pfam05649 152 DEKsaeIREAYKAYIAKLLTLLGASEE-AAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLAPGIDWKAY 230
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   341 MNALlpeGLNVAEDEMINLSVPSFFEDLGKLLAKTPKRVIANYMFWR-IHGFSvGFLSEEFRKRQLQYATALSGRQEQEa 419
Cdd:pfam05649 231 LNAA---GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRlVRSLA-PYLSDEFRDANFEFYGTLSGTKQRP- 305
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 17737761   420 RWKECVDIATSSLGISVGSLYVGKHFHKDSKANALEMVNEIRNVFNDILDEVNWMDAKTKKEAKLKLHSMATHIGYP 496
Cdd:pfam05649 306 RWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
557-762 6.77e-80

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 254.65  E-value: 6.77e-80
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   557 NAFYSSLENSIQFPAGILQGHFFNAQRPKYMNFGAIGYVIGHEITHGFDDQGRQFDVKGNLRDWWHPDTQKAYLAKAKCI 636
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761   637 IEQYGNYTERATGLNLNGINTQGENIADNGGVKESYIAYRRwaEKHGPEAKLPGLD-YTPEQMFWVAAGQTWCAKYRKES 715
Cdd:pfam01431  81 IEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKK--LLSANETVLPGFEnLTPDQLFFRGAAQIWCMKQSPAE 158
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*..
gi 17737761   716 LKMRITTGVHSPSEFRVLGSLSNMKDFAKDFHCPEGSPMNPVQKCEV 762
Cdd:pfam01431 159 VLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
518-614 3.21e-03

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 37.85  E-value: 3.21e-03
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17737761 518 KYFESFLGMNIFGTDYSFNKLRLPVNKtdwvrHARPAIVNAFYSSLENsIQFPAGILQGhffnaqrpkymnFGAIGYVIG 597
Cdd:cd09594   9 KYYEELLGRTSFRYPVSPIYSLLVYPA-----YVEVNAYNAMWIPSTN-IFYGAGILDT------------LSGTIDVLA 70
                        90
                ....*....|....*..
gi 17737761 598 HEITHGFDDQGRQFDVK 614
Cdd:cd09594  71 HELTHAFTGQFSNLMYS 87
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH